COMMUNIQUÉS West-GlobeNewswire

EssilorLuxottica: Mise à disposition du Document d’enregistrement universel 2023
08/03/2024
Mise à disposition du Document d’enregistrement universel 2023 Charenton-le-Pont, France (8 mars 2024 – 18h30) – EssilorLuxottica annonce la mise à disposition de son Document d’enregistrement universel 2023 dans les [...]
NeuroOne® to Participate in the 36th Annual Roth Conference
08/03/2024
EDEN PRAIRIE, Minn., March 08, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and [...]
MEDIA ADVISORY: New Report on Ottawa clinic exposes the “Wild West” created by Ontario’s rush to for-profit health care
08/03/2024
Attn: Assignment Editor OTTAWA, March 08, 2024 (GLOBE NEWSWIRE) -- A new report to be released Friday contains shocking revelations about the ownership and management behind private health clinics in Ottawa. Based on a [...]
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
08/03/2024
Company announcement – No. 13 / 2024 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, March [...]
Trinity Biotech Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
08/03/2024
DUBLIN, Ireland, March 08, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech Plc. (NASDAQ: TRIB) (the “Company”) today reported the receipt of a formal notification from The Nasdaq Stock Market LLC ("Nasdaq") that the Company [...]
Kymera Therapeutics Presents Preclinical Data for STAT6 and TYK2 First-In-Class, Oral Degrader Immunology Programs at the American Academy of Dermatology Annual Meeting
08/03/2024
KT-621 (STAT6) and KT-294 (TYK2) have the potential to provide biologics-like activity with oral small molecule profiles KT-621 (STAT6) expected to start Phase 1 in second half of 2024 and KT-294 (TYK2) expected to [...]
DBV Technologies announces filing of 2023 Annual Report on Form 10-K and Universal Registration Document
08/03/2024
Montrouge, France, March 8, 2024 DBV Technologies announces filing of 2023 Annual Report on Form 10-K and Universal Registration Document DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT [...]
DBV Technologies publie son « Form 10-K » américain et son Document d’Enregistrement Universel 2023
08/03/2024
Montrouge, France, le 8 mars 2024 DBV Technologies publie son « Form 10-K » américain et son Document d’Enregistrement Universel 2023 DBV Technologies (Euronext : DBV – ISIN : FR0010417345 - Nasdaq : DBVT), une société [...]
Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
08/03/2024
CARLSBAD, Calif., March 08, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the KeyBanc Capital Markets Life Sciences & [...]
Kane Biotech Receives Bioscience Association Manitoba Company of the Year Award
08/03/2024
WINNIPEG, Manitoba, March 08, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech” or “Kane”) announces that at the Bioscience Association of Manitoba (“BAM”) annual awards [...]
Acumen Pharmaceuticals Presents Sabirnetug (ACU193) Fluid Biomarker and Target Engagement Analyses from Phase 1 INTERCEPT-AD Study in Early Alzheimer’s at the AD/PD™ 2024 Annual Meeting
08/03/2024
- Cerebrospinal fluid (CSF) biomarker results are highly supportive of sabirnetug’s downstream pharmacological effects in the brain in early AD - Poster presentation showcases method used to develop a first-of-its-kind [...]
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
08/03/2024
Please see enclosed pdf. Attachment 08032024_trading_in_shares_LRA
Teladoc Health to Participate in Upcoming Investor Conference
08/03/2024
PURCHASE, NY, March 08, 2024 (GLOBE NEWSWIRE) -- Teladoc Health , Inc. (NYSE: TDOC), the global leader in whole-person virtual care, announced today that Jason Gorevic, chief executive officer, and Mala Murthy, chief [...]
ReStore Exo-Suit Publications Demonstrate Improved Walking Outcomes Versus Conventional Stroke Therapy
08/03/2024
Randomized clinical trial demonstrates significant improvements in walking ability for patients receiving therapy with the ReStore Exo-Suit as compared to a matched control group receiving conventional stroke therapy. [...]
Structure Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Highlights
08/03/2024
Topline GSBR-1290 Phase 2a 12-week obesity data, as well as data from formulation bridging and titration optimization study, on track for latter half of the second quarter 2024 Phase 2b study in obesity expected to [...]
MaNaDr's Weight Management Program Makes Waves at World Obesity Day Walk 2024 in Singapore
08/03/2024
SIngapore, March 08, 2024 (GLOBE NEWSWIRE) -- MaNaDr, a/k/a MOBILE-HEALTH NETWORK SOLUTIONS, a provider of comprehensive 24/7 telemedicine and healthcare products and services in the APAC region, today reported that the [...]
Onconova Therapeutics’ Rigosertib Poster Selected for AACR 2024
08/03/2024
Translational science to characterize pathways impacted by rigosertib may help to guide future clinical studies and combination treatment regimen for difficult-to-treat cancers NEWTOWN, Pa., March 08, 2024 (GLOBE [...]
SELLAS Announces Executive Leadership Reorganization and Prioritization of Commercialization Partnerships
08/03/2024
NEW YORK, March 08, 2024 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for [...]
Multi-Center Study Presented by Duke at Heart Failure Therapeutics Conference Highlights Daxor’s Unique Clinical Utility for Heart Failure Patients
08/03/2024
Only Daxor’s BVA Diagnostic Was Shown to Accurately Reflect Blood Volume Compared to Inferior Surrogates Oak Ridge, TN, March 08, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood [...]

Pages